Kardigan, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Kardigan, Inc. - overview
Established
2023
Location
South San Francisco, CA, US
Primary Industry
Biotechnology
About
Established in 2023, and based in California, US, Kardigan, Inc. engages in providing cardiovascular treatments. Kardigan is developing a portfolio of advanced cardiovascular therapeutics to modify the underlying causes of cardiovascular diseases. The offerings consist of late-stage clinical candidates that target critical disease drivers, facilitating effective patient segmentation and streamlined clinical trials.
By utilising a proprietary set of cardiac-specific tools, Kardigan validates markers for safety, efficacy, and patient selection in human studies. The company leverages real-world clinical data to enhance its understanding of cardiovascular diseases and the potential impact of its therapies. The products cater to healthcare providers, including hospitals and specialty clinics.
Current Investors
ARCH Venture Partners, Hong Shan, Perceptive Advisors
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Cardiology
Website
www.kardigan.bio
Verticals
Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.